Image Credit: Canva stock images After 21 years (and a few months), the California Institute of Regenerative Medicine (CIRM) has hit a major milestone: the first therapy supported by CIRM has been approved by the Food and Drug Administration for use in patients. In 2004, when California voters created CIRM to fund research with stem cells — cells that can divide to form many different tissues … Continue reading First therapy supported by CIRM approved by the FDA
Author: Amy Adams
New program to help patients with rare disease
Recently, the California Institute for Regenerative Medicine (CIRM) announced a new approach for how its funding can advance treatments for people living with rare diseases. Individually, few people have any single rare disease, but in aggregate, about 30 million people in the U.S. have one of the roughly 10,000 rare diseases, and 95% have no … Continue reading New program to help patients with rare disease
20 Years of CIRM: Building the Workforce
In celebration of the California Institute for Regenerative Medicine (CIRM)’s 20th anniversary, we have been reflecting on some of the early projects we supported and their outcomes.Today, we’re looking at our first set of grants, which we awarded in 2006 to support training programs for graduate students and postdoctoral fellows. Not long after, CIRM began … Continue reading 20 Years of CIRM: Building the Workforce